4-(2,4-dichlorophenyl)-5-(4-bromophenylcarbamoyl)-6-methyl-2-thioxo-1,2,3,4-tetrahydropyrimidine | 313392-22-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4-(2,4-dichlorophenyl)-5-(4-bromophenylcarbamoyl)-6-methyl-2-thioxo-1,2,3,4-tetrahydropyrimidine
• 英文别名: N-(4-bromophenyl)-4-(2,4-dichlorophenyl)-6-methyl-2-sulfanylidene-3,4-dihydro-1H-pyrimidine-5-carboxamide
• CAS: 313392-22-2
• 化学式: C₁₈H₁₄BrCl₂N₃OS
• 分子量: 471.205
• InChiKey: SUCVYXHDPQSGAM-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.5
• 重原子数：
  26
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.11
• 拓扑面积：
  85.2
• 氢给体数：
  3
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  4-(2,4-dichlorophenyl)-5-(4-bromophenylcarbamoyl)-6-methyl-2-thioxo-1,2,3,4-tetrahydropyrimidine 、 邻氯氯苄 在 potassium carbonate 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 以63%的产率得到4-bromophenyl 2-(2-chlorobenzylsulfanyl)-4-(2,4-dichlorophenyl)-6-methyl-1,4-dihydro-5-pyrimidinecarboxamide
  参考文献：
  名称：

  Antihypertensive activity of newer 1,4-dihydro-5-pyrimidine carboxamides: Synthesis and pharmacological evaluation

  摘要：

  A number of 5-(4-substituted phenyl)-2-(substiruted benzylsulfanyl)-4-(substituted phenyl)-6-methyl-1,4-dihydro-5-pyrimidine carboxamides (1-30) were designed and synthesized keeping in view the structural requirements as suggested in the pharmacophore model for antihypertensive activity. All the synthesized compounds were tested for antihypertensive activity by non-invasive blood pressure (NIBP) measurements (tail-cuff method) in rats. Almost all the tested compounds displayed considerable decrease in the blood pressure as compared to control. Thirteen compounds showed significant antihypertensive activity comparable to the standard drug nifedipine. (C) 2010 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2010.08.022
• 作为产物：
  描述：

  N-(4-溴苯基)-3-氧丁酰胺 、 2,4-二氯苯甲醛 、 硫脲 在 盐酸 作用下， 以 乙醇 、 水 为溶剂， 生成 4-(2,4-dichlorophenyl)-5-(4-bromophenylcarbamoyl)-6-methyl-2-thioxo-1,2,3,4-tetrahydropyrimidine
  参考文献：
  名称：

  Antihypertensive activity of newer 1,4-dihydro-5-pyrimidine carboxamides: Synthesis and pharmacological evaluation

  摘要：

  A number of 5-(4-substituted phenyl)-2-(substiruted benzylsulfanyl)-4-(substituted phenyl)-6-methyl-1,4-dihydro-5-pyrimidine carboxamides (1-30) were designed and synthesized keeping in view the structural requirements as suggested in the pharmacophore model for antihypertensive activity. All the synthesized compounds were tested for antihypertensive activity by non-invasive blood pressure (NIBP) measurements (tail-cuff method) in rats. Almost all the tested compounds displayed considerable decrease in the blood pressure as compared to control. Thirteen compounds showed significant antihypertensive activity comparable to the standard drug nifedipine. (C) 2010 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2010.08.022

文献信息

• Antihypertensive activity of newer 1,4-dihydro-5-pyrimidine carboxamides: Synthesis and pharmacological evaluation
  作者：Ozair Alam、Suroor A. Khan、Nadeem Siddiqui、Waquar Ahsan、Suraj P. Verma、Sadaf J. Gilani

  DOI：10.1016/j.ejmech.2010.08.022

  日期：2010.11

  A number of 5-(4-substituted phenyl)-2-(substiruted benzylsulfanyl)-4-(substituted phenyl)-6-methyl-1,4-dihydro-5-pyrimidine carboxamides (1-30) were designed and synthesized keeping in view the structural requirements as suggested in the pharmacophore model for antihypertensive activity. All the synthesized compounds were tested for antihypertensive activity by non-invasive blood pressure (NIBP) measurements (tail-cuff method) in rats. Almost all the tested compounds displayed considerable decrease in the blood pressure as compared to control. Thirteen compounds showed significant antihypertensive activity comparable to the standard drug nifedipine. (C) 2010 Elsevier Masson SAS. All rights reserved.